Stocks and Investing Stocks and Investing
Tue, May 14, 2024
Mon, May 13, 2024

Oren Livnat Maintained (ANIP) at Strong Buy with Increased Target to $87 on, May 13th, 2024


Published on 2024-10-28 11:19:20 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $83 to $87 on, May 13th, 2024.

Oren has made no other calls on ANIP in the last 4 months.



There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Oren's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Oren


  • Vamil Divan of "Guggenheim" Reiterated at Strong Buy and Held Target at $77 on, Tuesday, April 23rd, 2024
  • Timothy Chiang of "Capital One" Initiated at Buy on, Friday, March 15th, 2024
  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Friday, March 1st, 2024

Contributing Sources